Form 4: American Oncology Network Director Receives Stock Grant
SEC Form 4 Filing
William Valle, a director at American Oncology Network, Inc., received a grant of 5,000 shares of Class A Common Stock.
Summary
- William Valle, a director of American Oncology Network, Inc. (AONC), reported a transaction on July 16, 2024, where he acquired 5,000 shares of Class A Common Stock.
- These shares were granted for his service as an independent director.
- 3,250 shares will vest over four years based on a time-based schedule, while 1,750 shares will vest based on performance.
- Following this transaction, Valle beneficially owns 19,981 shares of Class A Common Stock.
Sentiment
Score: 7
Explanation: The document reflects a standard corporate governance practice of granting stock to directors, which is generally viewed positively as it aligns interests. There are no indications of negative news or concerns.
Positives
- The grant of shares to a director aligns their interests with the company's success.
- The vesting schedule encourages long-term commitment and performance.
Industry Context
Stock grants to directors are a common practice in corporate governance to incentivize and align their interests with the company's performance. This is typical compensation for board members, especially in growth-oriented companies.
Comparison to Industry Standards
- Stock grants to board members are a common practice across the industry.
- Companies like McKesson, Cardinal Health, and AmerisourceBergen also use stock grants as part of their director compensation packages.
- The vesting schedules (time-based and performance-based) are also standard in the industry to ensure long-term commitment and alignment with company goals.
Stakeholder Impact
- Shareholders may view the stock grant positively as it aligns the director's interests with the company's performance.
- Employees may see it as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| April 3, 2024 | Date of Limited Power of Attorney execution. |
| 07/16/2024 | Date of the stock grant transaction. |
| 07/18/2024 | Date of signature by attorney-in-fact. |
Keywords
Form 4, Beneficial Ownership, Director, Stock Grant, AONC, American Oncology Network, William Valle
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.